This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Movement Disorders  • Parkinson Disease/ Parkinsonian Disorders  • Alert me on articles by topic

Arch Neurol. 2002;59:699-702.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

ADVANCES IN neurophysiology, pharmacology, surgical technology, and molecular biology have provided the basis for contemporary therapies (Table 1) for movement disorders. This article will focus on the treatment of 4 conditions commonly seen in a movement disorder practice: Parkinson disease (PD), dystonia, essential tremor, and tic disorders.

Table appears in full text version. Commonly Used Oral Drugs for Movement Disorders

PARKINSON DISEASE

Symptomatic therapy for patients with early signs of PD is generally delayed until there is functional impairment.¹ In the meantime, the issue of putative neuroprotection can be addressed with the patient. So far, there is no medication that has been unequivocally proven to halt or slow disease progression. Research on new potential neuroprotective agents is ongoing, and antiapoptotic agents, antioxidants, and drugs that interrupt the excitotoxic cascade are currently under study. Facilitating access to study centers for participation in clinical trials is an important intervention for interested subjects. The Parkinson Study Group is a . . . [Full Text of this Article]

DYSTONIA

ESSENTIAL TREMOR

TIC DISORDERS

RELATED ARTICLE

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2002;59(5):878-880.
FULL TEXT